Heart & Vascular Institute

Heart & Vascular Institute Education and Events

Temple Heart & Vascular Institute Faculty Provide Critical Insights for the Diagnosis and Management of CTEPH

Join Temple at the U.S. CTEPH Proceedings 2021 in Philadelphia

The U.S. CTEPH Proceedings conference is coming to Philadelphia September 10-11, 2021 and the Temple Pulmonary Hypertension, Right Heart Failure, CTEPH/BPA/PTE team will be well-represented.

Temple is home to the largest pulmonary thromboendarterectomy (PTE) program on the East Coast, approaching its 300th surgery since the program’s inception in 2013 — second most in the U.S. over that time period.

Temple has also had a >97% survival in the past 3 years — among the best outcomes in the nation, a remarkable feat as the program cares for high volume and complex patients from all over the USA.  

Don’t miss this important conference, which offers cardiologists and pulmonologists the chance to learn more about how to better evaluate and manage patients with CTEPH. It also offers an opportunity to meet and hear from experts in CTEPH care, including many members of Temple’s Pulmonary Hypertension, Right Heart Failure, CTEPH/BPA/PTE team.

Temple Presenters

Life After PTE: Residual PH Assessment and Mechanical VTE Risk Mitigation
Anjali Vaidya, MD, FACC, FASE, FACP

Exercise Testing in Chronic PE
Paul Forfia, MD

Technical Considerations and Challenges in BPA
Riyaz Bashir, MD

BPA Combined with Medical Management in Inoperable CTEPH
Vladimir Lakhter, DO

Temple Experts Moderating Subsections

Nonsurgical Management of CTEPH
Anjali Vaidya, MD, FACC, FASE, FACP

Surgery, Surgical Management, and Cases That Drive Our Surgical Colleagues Nuts!
Yoshiya Toyoda, MD, PhD

Balloon Pulmonary Angioplasty: The New Frontier
Riyaz Bashir, MD

Interactive Case Presentations
Paul Forfia, MD

Accepted Abstracts

Coronary to Pulmonary Collaterals: CTEPH Implications
Labrada L, Oliveros E, Lakhter V, Forfia PR, Auger WR, Bashir R, Vaidya A.

SARS-CoV-2 Infection after CTEPH Diagnosis Associated with Vascular Tissue Friability during Pulmonary Thromboendarterectomy
Jonnalagadda A, Forfia PR, Taraif S, Auger WR, Oliveros E, Toyoda Y, Vaidya A.

Novel CTEPH mimickers in the COVID-19 era
Pietrowicz R, Oliveros E, Lavenburg P, Lakhter V, Bashir R, Toyoda Y, Forfia PR, Vaidya A

Use of Shape-HFTM system for point-of-care Cardiopulmonary Exercise Testing of Patients with  CTEPH and CTED; a preliminary analysis
Oliveros E, Lee M, Tanis M, Lakhter V, Bashir R, Auger WR, Vaidya A, Forfia PR

Pelvic Vein Obstruction in Patients with Chronic Thromboembolic Pulmonary Hypertension: An Important Clinical Association
Vaidya A, Vaidy A, Al-Otaibi M, Zlotshewer BS, Oliveros E, Zhao H, Lakhter V, Auger WR, Forfia PR, Bashir R

Thyroid Storm from Graves’ Disease associated with Severe Pulmonary Hypertension after Pulmonary Thromboendarterectomy for CTEPH
Carabelli E, Lavenburg P, Bashir R, Forfia PR, Auger WR, Lakhter V, Oliveros E, Vaidya A.

Balloon Pulmonary Angioplasty in CTEPH associated with Inherited Red Blood Cell Dyscrasias
Maqsood N, Lakhter V, Oliveros E, Forfia PR, Auger WR, Bashir R, Vaidya A.

Obesity Blunts Gas Exchange Evidence of Ventilatory Inefficiency in Patients with Chronic Thromboembolic Disease
Oliveros E, Pietrowicz R, Lakhter V, Basihr R, Auger WR, Vaidya A. Forfia PR.

Echo-Doppler Predictors of Residual Pulmonary Hypertension Requiring Intervention Post Pulmonary Thromboendarterectomy
Jonnalagadda A, Oliveros E, Pietrowicz R, Lee M, Vaidya A, Forfia PR

Balloon Pulmonary Angioplasty - Clinical and Hemodynamic Outcomes of  US Regional CTEPH Program
Bashir R, Noory A, Mirza A, Oliveros E, Lakhter V, Brisco-Bacik M, Auger WR, Vaidya A, Forfia PR